TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Terumo Corporation. The primary component is Anhydrous Citric Acid; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Dextrose Monohydrate; Adenine.
Product ID | 53877-001_05957b63-ef61-4c95-b683-7bb697ae2a89 |
NDC | 53877-001 |
Product Type | Human Prescription Drug |
Proprietary Name | TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) |
Generic Name | Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2012-05-22 |
Marketing Category | NDA / NDA |
Application Number | BN820528 |
Labeler Name | Terumo Corporation |
Substance Name | ANHYDROUS CITRIC ACID; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; DEXTROSE MONOHYDRATE; ADENINE |
Active Ingredient Strength | 3 g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL |
Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-05-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-14 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-16 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-10 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-14 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-11-18 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-05-22 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-10 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-14 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-16 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-14 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-12-14 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-05-22 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-05-22 |
Marketing Category | NDA |
Application Number | BN820528 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-05-22 |
Ingredient | Strength |
---|---|
ANHYDROUS CITRIC ACID | 2.99 g/1000mL |
SPL SET ID: | 6b6f4a15-7bb0-4092-b43d-b423f14ec12f |
Manufacturer | |
UNII |